Clinical Trials Browser

Phase 2 × Non-Small Cell Lung Cancer With EGFR T790M Mutation × osimertinib × Clear all

NCT03257124 2021-08-16

Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS

Phase 2 Unknown

Non-Small Cell Lung Cancer With EGFR T790M Mutation